Application Process
Application Tips
ERAS
GME
IMG
Preference Signaling
Thalamus
Tips
Transition to Residency
Published on / 
June 10, 2022

The Ultimate Guide to Preference Signaling for Medical Residency Applicants and Programs 2022-2023. Part 5: How Thalamus will support Preference Signaling for Programs in 2022-2023

The Ultimate Guide to Preference Signaling for Medical Residency Applicants and Programs 2022-2023. Part 5: How Thalamus will support Preference Signaling for Programs in 2022-2023

This 5-part blog series, The Ultimate Guide to Preference Signaling for Medical Residency for Applicants and Programs 2022-2023 includes:

This is Part 5: How Thalamus will support Preference Signaling for Programs in 2022-2023.

How Thalamus Incorporates Preference Signaling into its Software:

Given the wider adoption of preference signaling for the 2022-2023 ERAS and Match recruitment season, Thalamus is excited to announce that we plan to fully support this initiative for our Thalamus program users! Thalamus will integrate preference signaling into our products and features as follows.

  • Support of preference signaling data in Thalamus Core and/or Cortex:  There has been a lot of interest in incorporating ERAS signaling data into Thalamus/Cortex for ease of screening and applicant review/data tracking. Thus, CSV uploaded will be included to accommodate faculty and program leadership in promoting holistic review.
  • Tagging/Denoting Applicants who preference signaled: Thalamus includes a unique tagging feature (link to user guide article) that allows program users to create “post-it” notes that are customized by text and color to denote important pieces of information. These tags are not only filterable, but also included on our various reports.

For programs interested in learning more about how Thalamus, Cortex, and Cerebellum can assist your preference signaling process this upcoming interview season contact us at sales@thalamusgme.com or request a demo.

Summary: Preference Signaling for Applicants and Programs 2022-2023.

Overall, the 2022-2023 residency recruitment cycle will include broader use of preference signaling, including 19 total specialties.  Initial outcomes data appear positive, though effects on application, interview and match statistics require further study. The allocation of signals, as well as the guideline of whether to signal either home programs or away rotations, varies widely amongst specialties, prompting different recommendations for each sub-category (few, more and many preference signals). There are varying opinions and guidelines on how preference signaling will be used, including as a screening tool, as part of holistic review, post-interviews and during rank list composition. Some uses are governed and protected by the NRMP Match Participation Agreement, but others appear more broadly interpretable. Regardless, it will be very interesting to observe the overall effects of preference signaling on the Match process and Thalamus is there to assist every step of the way!

News & Press

Explore our latest insights and updates.

Cortex Core Clerkship Grades and Transcript Normalization
GME
ERAS
Thalamus
October 6, 2025
Cortex Core Clerkship Grades and Transcript Normalization

Read
Right Arrow
Methodology for creation and processing of a novel Transcript Normalization Tool in Cortex Application Screening and Review Platform
Data & Analysis
ERAS
GME
Product Releases
Program Coordinators
September 29, 2025
Methodology for creation and processing of a novel Transcript Normalization Tool in Cortex Application Screening and Review Platform

Learn how Thalamus AI Insights standardizes medical school transcripts for ERAS 2026, improving fairness, consistency, and efficiency in residency review.

Read
Right Arrow
Artificial Intelligence: The Thalamus Way
Data & Analysis
GME
Thalamus
September 22, 2025
Artificial Intelligence: The Thalamus Way

Read
Right Arrow